Oxford Pharmascience Group Plc Company Profile (LON:OXP)

About Oxford Pharmascience Group Plc (LON:OXP)

Oxford Pharmascience Group Plc logoOxford Pharmascience Group plc is a United Kingdom-based specialty pharmaceutical company. The Company is engaged in re-developing medicines. The Company primarily engages in research and development activities based around its core technology platforms and focuses on commercializing the related products to pharmaceutical organizations. It operates through one segment, being the development and commercialization of drug products from proprietary technology platforms. The Company operates in three main geographic areas, such as the United Kingdom, Middle East and Brazil. The Company is primarily focused on commercialization efforts for its compounds OXPzero Ibuprofen and OXPzero Naproxen and in regulatory, technical and clinical activities in support of these assets. It is focused on establishing a number of commercial partnerships that demonstrate the commercial feasibility of the technology. The Company's subsidiaries include Oxford Pharmascience Limited and Oxford Nutra Limited.

Industry, Sector and Symbol:
  • Sector: N/A
  • Industry: N/A
  • Sub-Industry: N/A
  • Symbol: LON:OXP
  • CUSIP: N/A
  • Web: N/A
Capitalization:
  • Market Cap: £19.89 million
  • Outstanding Shares: 1,205,661,000
Average Prices:
  • 50 Day Moving Avg: GBX 1.78
  • 200 Day Moving Avg: GBX 2.11
  • 52 Week Range: GBX 1.50 - GBX 7.32
P/E:
  • Trailing P/E Ratio: N/A
  • P/E Growth: 0.00
Sales & Book Value:
  • Annual Revenue: $796,000.00
  • Price / Sales: 24.99
  • Book Value: GBX 0.02 per share
  • Price / Book: 0.83
Profitability:
  • EBIDTA: ($2,020,000.00)
Misc:
  • Average Volume: 1.52 million shs.
 

Frequently Asked Questions for Oxford Pharmascience Group Plc (LON:OXP)

What is Oxford Pharmascience Group Plc's stock symbol?

Oxford Pharmascience Group Plc trades on the London Stock Exchange (LON) under the ticker symbol "OXP."

Who are some of Oxford Pharmascience Group Plc's key competitors?

How do I buy Oxford Pharmascience Group Plc stock?

Shares of Oxford Pharmascience Group Plc and other U.K. stocks can be purchased through online brokerage accounts that support trading on the London Stock Exchange (LSX). Some U.K. companies can be purchased through major U.S. brokerages in the form of American Depository Receipts (ADRs), which are placeholder equities held in a trust by a bank that represent shares of a foreign stock.

How much does a share of Oxford Pharmascience Group Plc stock cost?

One share of Oxford Pharmascience Group Plc stock can currently be purchased for approximately GBX 1.65.

Analyst Ratings

Consensus Ratings for Oxford Pharmascience Group Plc (LON:OXP) (?)
Ratings Breakdown: 1 Hold Rating
Consensus Rating:Hold (Score: 2.00)
Consensus Price Target: N/A

Analysts' Ratings History for Oxford Pharmascience Group Plc (LON:OXP)
Show:
DateFirmActionRatingPrice TargetDetails
5/9/2017N+1 SingerReiterated RatingcorporateView Rating Details
7/21/2016Beaufort SecuritiesDowngradeHoldView Rating Details
(Data available from 5/26/2015 forward)

Earnings

Earnings History for Oxford Pharmascience Group Plc (LON:OXP)
No earnings announcements for this company have been tracked by MarketBeat.com

Estimates

Earnings Estimates for Oxford Pharmascience Group Plc (LON:OXP)

No earnings estimates for this company have been tracked by MarketBeat.com

Dividends

Dividend History for Oxford Pharmascience Group Plc (LON:OXP)
No dividend announcements for this company have been tracked by MarketBeat.com

Insider Trades

Insider Trading History for Oxford Pharmascience Group Plc (LON:OXP)
No insider trades for this company have been tracked by MarketBeat.com

Headlines

Headline Trends for Oxford Pharmascience Group Plc (LON:OXP)
Latest Headlines for Oxford Pharmascience Group Plc (LON:OXP)
Source:
DateHeadline
americanbankingnews.com logoOxford Pharmascience Group Plc (OXP) Stock Rating Reaffirmed by N+1 Singer
www.americanbankingnews.com - May 9 at 1:26 PM
morningstar.co.uk logoOxford Pharmascience Well-Funded For Development As 2016 Loss Narrows
www.morningstar.co.uk - March 10 at 9:11 AM
morningstar.co.uk logoOxford Pharmascience Interim Loss Narrows As New Products Near Launch
www.morningstar.co.uk - September 8 at 10:30 AM
biz.yahoo.com logoHalf Year 2016 Oxford Pharmascience Group PLC Earnings Release - Time Not Supplied
biz.yahoo.com - September 7 at 10:11 AM
biz.yahoo.com logoFull Year 2015 Oxford Pharmascience Group PLC Earnings Release - Time Not Supplied
biz.yahoo.com - March 4 at 7:07 AM
bloomberg.com logoOxford Pharmascience Climbs on Search for Marketing Partner
www.bloomberg.com - January 25 at 4:40 AM
noodls.com logoNaproxen Progresses into Proof of Concept Trials
us.rd.yahoo.com - January 14 at 11:02 AM
noodls.com logoNSAIDs Programme & Year End Financial Review
us.rd.yahoo.com - January 14 at 11:02 AM
noodls.com logoSuccessful Pilot Clinical Study
us.rd.yahoo.com - January 14 at 11:02 AM
noodls.com logoPK Results for OXPzero Naproxen vs. Naprosyn
us.rd.yahoo.com - January 14 at 11:02 AM
noodls.com logoIbuprofen progressing to proof of concept trial
us.rd.yahoo.com - January 14 at 11:02 AM
noodls.com logoInitiation of Pilot Clinical Study for Naproxen
us.rd.yahoo.com - January 14 at 11:02 AM
noodls.com logoProposed Placing
us.rd.yahoo.com - January 14 at 11:02 AM
noodls.com logoGrant of Share Options
us.rd.yahoo.com - January 14 at 11:02 AM
noodls.com logoPosting of Circular and Notice of GM
us.rd.yahoo.com - January 14 at 11:02 AM
noodls.com logoResult of GM
us.rd.yahoo.com - January 14 at 11:02 AM
noodls.com logoInitiation of Pilot Clinical Study
us.rd.yahoo.com - January 14 at 11:02 AM
noodls.com logoInitiation of Pilot Clinical Study for Ibuprofen
us.rd.yahoo.com - January 14 at 11:02 AM
noodls.com logoResults from Pilot Clinical Study of OXP500
us.rd.yahoo.com - January 14 at 11:02 AM
noodls.com logoPreliminary PK Data & Initiation of Further Study
us.rd.yahoo.com - January 14 at 11:02 AM

Social

Social activity is not available for this stock.

Chart

Oxford Pharmascience Group Plc (OXP) Chart for Friday, May, 26, 2017

This page was last updated on 5/26/2017 by MarketBeat.com Staff